Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
2.180
+0.020 (0.93%)
Jul 23, 2025, 11:23 AM - Market open
Conduit Pharmaceuticals Employees
Conduit Pharmaceuticals had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$3,232,667
Market Cap
5.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CDT News
- 15 days ago - Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy - GlobeNewsWire
- 16 days ago - Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries - GlobeNewsWire
- 7 weeks ago - Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset - GlobeNewsWire